What are the diagnostic criteria, severity classification, and management recommendations for pediatric acute respiratory distress syndrome (PARDS) according to the PALICC 2 guidelines?

PALICC-2 Guidelines for Pediatric Acute Respiratory Distress Syndrome

The PALICC-2 guidelines (2023) provide updated diagnostic criteria, severity stratification, and management recommendations for pediatric acute respiratory distress syndrome, representing the most comprehensive evidence-based approach to PARDS diagnosis and treatment. 1

Diagnostic Criteria

PARDS diagnosis requires all of the following components occurring within 7 days of a known clinical insult 1:

Core Diagnostic Elements:

• Timing: Acute onset within 1 week of known clinical insult
• Imaging: Bilateral opacities on chest imaging (chest radiograph or CT) not fully explained by effusions, lobar/lung collapse, or nodules. Notably, PALICC-2 allows unilateral findings in pediatric patients, unlike adult definitions 2
• Origin of edema: Respiratory failure not fully explained by cardiac failure or fluid overload
• Oxygenation impairment: Documented hypoxemia (see severity classification below)

Special Populations:

PALICC-2 explicitly includes patients with chronic lung disease or cyanotic congenital heart disease when acute deterioration is documented, addressing a critical gap in previous definitions 2. This represents a major advancement in recognizing PARDS in complex pediatric populations.

Resource-Limited Settings:

When imaging is unavailable but all other criteria are met including noninvasive metrics of hypoxemia, the diagnosis of "possible PARDS" can be made to avoid underdiagnosis 3.

Severity Classification

PARDS severity differs fundamentally from adult ARDS by incorporating Oxygenation Index (OI) and Oxygen Saturation Index (OSI), which integrate mean airway pressure and correlate more strongly with short-term outcomes than PaO2/FiO2 ratios alone 2, 4.

For Invasively Mechanically Ventilated Patients:

Using OI = (FiO2 × Mean Airway Pressure × 100) / PaO2:

• Mild PARDS: OI 4 to <8 or OSI 5 to <7.5
• Moderate PARDS: OI 8 to <16 or OSI 7.5 to <12.3
• Severe PARDS: OI ≥16 or OSI ≥12.3

Using PaO2/FiO2 ratio (when OI unavailable):

• Mild: 200-300 mmHg
• Moderate: 100-200 mmHg
• Severe: <100 mmHg

For Noninvasively Ventilated Patients:

PALICC-2 includes specific criteria for patients on NIV/CPAP with full face mask:

• Requires bilateral imaging findings
• SpO2/FiO2 ratio ≤264 (equivalent to PaO2/FiO2 ≤300)
• Minimum PEEP ≥5 cmH2O

This severity classification has direct prognostic implications: HRQL decline occurred in 28% with mild PARDS, 38% with moderate, and 70% with severe PARDS, demonstrating clear dose-response relationship 4.

Management Recommendations

Initial Respiratory Support Strategy

For patients without clear indication for intubation and responding to initial resuscitation, trial noninvasive mechanical ventilation over immediate invasive ventilation 5, 6. However, this requires:

• Close monitoring with experienced staff
• Frequent re-evaluation for signs of worsening (declining SpO2/FiO2 ratio is key predictor of NIV failure)
• Low threshold for intubation if deterioration occurs 6

Invasive Mechanical Ventilation Settings

When invasive ventilation is required:

Tidal Volume:

• Use ≤6 mL/kg ideal body weight (strong recommendation) 7
• May need lower volumes in lung hypoplasia syndromes 8

PEEP Strategy:

• Use high PEEP (strong recommendation, moderate certainty) - this is the only strong recommendation in PALICC-2 ventilation management 7
• Start with 5-8 cmH2O, titrate higher based on disease severity 8
• Use ARDS-network PEEP-to-FiO2 grid, though be cautious of hemodynamic effects in septic shock 5
• Consider PEEP titration and lung recruitment maneuvers 8, 7

Plateau Pressure:

• Keep ≤28-29 cmH2O with increased chest wall elastance
• Keep ≤30 cmH2O in obstructive airway disease 8

Driving Pressure and Mechanical Power:

• Monitor and minimize driving pressure (plateau pressure - PEEP)
• Consider mechanical power as emerging metric 7

Recruitment Maneuvers

If recruitment maneuvers are considered for refractory hypoxemia:

• Use stepwise, incremental and decremental PEEP titration
• Avoid sustained inflation techniques - these have not been optimized in PARDS 5
• Monitor carefully for hemodynamic tolerance 5

Adjunctive Therapies - Algorithmic Approach

For Severe PARDS (OI ≥16 or OSI ≥12.3):

Step 1: Prone Positioning

• Trial prone positioning for at least 12 hours per day (weak recommendation, low quality evidence) 5, 7
• This should be implemented early in severe PARDS

Step 2: Neuromuscular Blockade

• Use neuromuscular blockade in severe PARDS (weak recommendation, very low quality evidence) 5
• Duration: 24-48 hours after ARDS onset based on adult RCT and pediatric observational data 5

Step 3: Inhaled Nitric Oxide

• Do NOT use iNO routinely (strong recommendation) 5
• Use iNO as rescue therapy ONLY after optimizing other oxygenation strategies (weak recommendation, moderate quality evidence) 5
• This means iNO should come after prone positioning and neuromuscular blockade

Step 4: High-Frequency Oscillatory Ventilation

• No recommendation for or against HFOV versus conventional ventilation 5
• May be considered if conventional ventilation fails, but evidence is insufficient 9

Step 5: Extracorporeal Support

• Consider ECMO for severe PH or hypoxemia refractory to all above interventions 10

Critical Pitfalls to Avoid

1. Do not use etomidate for intubation in septic shock or sepsis-associated organ dysfunction (weak recommendation) 5

2. Do not routinely use iNO - it is strongly recommended against routine use and should only be rescue therapy 5

3. Do not delay prone positioning in severe PARDS - it should be implemented before considering iNO 5

4. Do not use sustained inflation recruitment maneuvers - use stepwise PEEP titration instead 5

5. Monitor for NIV failure closely - declining SpO2/FiO2 ratio indicates need for intubation 6

Monitoring Parameters

Essential monitoring includes 8:

• SpO2 in all patients (target 92-97% when PEEP <10 cmH2O; 88-92% when PEEP ≥10 cmH2O)
• Arterial or capillary PCO2 (target pH >7.20, accept permissive hypercapnia)
• Peak inspiratory pressure, plateau pressure, mean airway pressure, PEEP
• Pressure-time and flow-time scalars
• Consider transpulmonary pressure monitoring in trained hands

Weaning Strategy

• Start weaning as soon as possible
• Perform daily extubation readiness testing
• Consider NIV in neuromuscular patients post-extubation 8

Outcomes and Prognosis

PARDS severity directly correlates with outcomes: 41.5% of PARDS patients experience clinically important HRQL decline (≥4.5 points), compared to 23.4% without PARDS 4. The risk increases with severity, making early aggressive management of severe PARDS critical for long-term quality of life outcomes.

The PALICC-2 guidelines emphasize that HRQL decline from baseline may be an efficient and clinically meaningful endpoint for PARDS clinical trials, reflecting the importance of prioritizing quality of life outcomes 4.